Showing results (1221-1230 of 1,406) with videos related to

Sort By:
Pageof 141
Nature Medicine|December 9, 2023
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trialOthman Al-Sawaf, Rudy Ligtvoet, Sandra Robrecht, et al.
Cytometry. Part B, Clinical Cytometry|August 15, 2006
Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization processRemi Letestu, Andy Rawstron, Paolo Ghia, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2017
Generalized myoclonic epilepsy with photosensitivity in juvenile dogs caused by a defective DIRAS family GTPase 1Franziska Wielaender, Riika Sarviaho, Fiona James, et al.
Journal of Medicinal Chemistry|November 22, 2024
Discovery of NP3-253, a Potent Brain Penetrant Inhibitor of the NLRP3 InflammasomeAngela Mackay, Juraj Velcicky, Nina Gommermann, et al.
Cancer Research|March 31, 2025
The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative EffectNancy Klemm, Roman R Schimmer, Nils K Konrad, et al.
Blood|August 18, 2023
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancyPeter G Miller, Adam S Sperling, Christina Mayerhofer, et al.
Blood|July 31, 2020
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotypeDavid A Sallman, Amy F McLemore, Amy L Aldrich, et al.
Family Process|May 16, 2025
Evaluation of the Health-Related Quality of Life and Mental Health of Parents With Children and Adolescents With a Rare Disease Based on the Results of a Randomized Controlled Trial to Investigate a Family-Based Intervention and an Online Intervention for Affected Families (CARE-FAM-NET)Antonia Steinberg, Johannes Boettcher, Anna Leidger, et al.
Nature Microbiology|September 5, 2018
Publisher Correction: Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidinAngelino T Tromp, Michiel Van Gent, Pauline Abrial, et al.
Science (New York, N.Y.)|August 10, 2019
A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignanciesSteffen Boettcher, Peter G Miller, Rohan Sharma, et al.
Pageof 141